N
NCEL
NewcelX Ltd
2.930
-0.220-6.98%After Hours: 2.850 -0.080 -2.73%18:50 06/05 EDT
OPEN/PREV CLOSE3.070/3.150
TODAY RANGE2.842-3.195
VOL17.19K
MARKET CAP15.66M
52 WEEK RANGE1.830-30.80
AVG VOL (3M)55.03K
% TURNOVER0.32%
TURNOVER--
P/E (TTM)-1.3570
% RANGE11.21%
EPS(TTM)-2.1592
P/E(FORWARD)-0.0163
P/B1.939
BVPS1.511
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.58M
SHARES OUTSTANDING5.35M
NEXT EARNINGS--
FREE FLOAT1.90M
LOT SIZE1
EX-DATE09/27/2024
News
Press Releases
Financial Reports
Profile
TipRanks·05/27 14:42
NewcelX submits NCEL-101 pre-investigational new drug briefing package to FDA
TipRanks·05/27 12:29
NewcelX Files Pre-IND With FDA for NCEL-101 Type 1 Diabetes Cell Therapy
Reuters·05/27 11:55
NEWCELX AG - TYPE B PRE-IND MEETING WITH FDA SCHEDULED FOR LAST WEEK OF JUNE
Benzinga·05/27 11:31
EXCLUSIVE: NewcelX Advances Diabetes Therapy Toward Human Trials With FDA Pre-IND Submission
TipRanks·05/11 22:55
NewcelX files to sell 2.26M common shares for holders
Seeking Alpha·05/01 12:48
NLS Pharmaceutics GAAP EPS of -$2.16
Benzinga·04/30 17:05
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·04/30 12:56
NewcelX FY EPS $(2.16) Up From $(2.43) YoY
Benzinga·04/30 12:01
EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug
Same Industry
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.